Sesen Bio, Inc.
SESN · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $26 | $6 | $7 | $8 |
| - Cash | $18 | $113 | $163 | $52 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $11 | -$106 | -$155 | -$44 |
| Revenue | $0 | $40 | $27 | $11 |
| % Growth | -100% | 50.7% | 136.2% | – |
| Gross Profit | $0 | $40 | $27 | $11 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | $0 | -$51 | -$9 | -$21 |
| % Margin | – | -127.1% | -32.2% | -187.6% |
| Net Income | -$60 | -$20 | -$0 | -$22 |
| % Margin | – | -49.7% | -1.3% | -199.3% |
| EPS Diluted | -1.46 | -1.99 | -0.037 | -3.8 |
| % Growth | 26.6% | -5,293% | 99% | – |
| Operating Cash Flow | -$60 | $25 | -$69 | -$31 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$60 | $25 | -$69 | -$31 |